Udall Project 2 Aim 2A&C

This protocol will leverage the novel (on-label, FDA-approved) local field potential measuring capability of the Medtronic Percept™ PC or RC DBS system to study the effects of globus pallidus internus, globus pallidus externus (GPi, GPe), and subthalamic nucleus (STN) DBS on: the wash-out and wash-in dynamics of motor behavior and local field potentials (LFPs) and correlations between fluctuations in gait and LFPs during activities of daily living (recorded over a minimum of 4 weeks). These experiments will elucidate the relationships between LFPs oscillations, lower limb function, postural control and gait performance.

Study identifier: NCT05656586. Status: RECRUITING.

Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.

View the official ClinicalTrials.gov record for NCT05656586

Browse Parkinson's clinical trials